Cargando…
2695. Pneumocystis jirovecii Pneumonia in the Era of Effective Prophylaxis Following Hematopoietic Stem Cell Transplant
BACKGROUND: Pneumocystis jirovecii pneumonia is an uncommon and life-threatening disease that can occur following hematopoietic stem cell transplantation (HSCT). Trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis greatly reduces the incidence of PJP. We aim to determine what factors contribute to t...
Autores principales: | Drelick, Alexander Christian, Kodiyanplakkal, Priya, Plate, Markus, Satlin, Michael J, Soave, Rosemary, Shore, Tsiporah, Besien, Koen Van, Small, Catherine, Walsh, Thomas J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809972/ http://dx.doi.org/10.1093/ofid/ofz360.2372 |
Ejemplares similares
-
Coronavirus Infection in Hematopoietic Stem Cell Transplant Recipients
por: Eichenberger, Emily, et al.
Publicado: (2017) -
532. COVID-19 Pneumonia in Patients with Hematologic Malignancies – A Report from the US Epicenter
por: Plate, Markus, et al.
Publicado: (2020) -
Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell–Depleted Stem Cell Transplantation
por: Chaekal, Ok-kyong, et al.
Publicado: (2022) -
Incidence, significance, and persistence of human coronavirus infection in hematopoietic stem cell transplant recipients
por: Eichenberger, Emily M., et al.
Publicado: (2018) -
Pneumocystis jirovecii pneumonia in liver transplant recipients in an era of routine prophylaxis
por: Andreasen, Philip B., et al.
Publicado: (2021)